Medicinal Use of Testosterone and Related Steroids Revisited

Plants in the management of male infertility

(2020) Sunny O. Abarikwu et al.   ANDROLOGIA

Anabolic androgenic steroid abuse in young males

(2020) Willem de Ronde et al.   Endocrine Connections

Long-term treatment with testosterone undecanoate injections in men with hypogonadism alleviates erectile dysfunction and reduces risk of major adverse cardiovascular events, prostate cancer, and mortality

(2019) Farid Saad et al.   Aging Male

Targeting the administration of ecdysterone in doping control samples

(2019) Maria Kristina Parr et al.   Forensic Toxicology

Studies on the in vivo metabolism of methylstenbolone and detection of novel long term metabolites for doping control analysis

(2019) Thomas Piper et al.   Drug Testing and Analysis

Post-finasteride syndrome: An emerging clinical problem

(2019) Silvia Diviccaro et al.   Neurobiology of Stress

Selective Androgen Receptor Modulator, YK11, Up-Regulates Osteoblastic Proliferation and Differentiation in MC3T3-E1 Cells

(2018) Tomofumi Yatsu et al.   BIOLOGICAL & PHARMACEUTICAL BULLETIN

Development of selective androgen receptor modulators (SARMs)

(2018) Ramesh Narayanan et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Testosterone Deficiency, Weakness, and Multimorbidity in Men

(2018) Mark D. Peterson et al.   Scientific Reports

HUMAN IN-VIVO METABOLISM STUDY OF LGD-4033

(2018) A.G. Fragkaki et al.   Drug Testing and Analysis

Single dose sublingual testosterone and oral sildenafilvs. a dual route/dual release fixed dose combination tablet: a pharmacokinetic comparison

(2016) Jos Bloemers et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Investigation of the selective androgen receptor modulators S1, S4 and S22 and their metabolites in equine plasma using high-resolution mass spectrometry

(2016) Annelie Hansson et al.   RAPID COMMUNICATIONS IN MASS SPECTROMETRY

FIVE-YEAR OUTCOMES AFTER LONG-TERM OXANDROLONE ADMINISTRATION IN SEVERELY BURNED CHILDREN

(2016) Patrick T. Reeves et al.   SHOCK

Study Design and Rationale for the Phase 3 Clinical Development Program of Enobosarm, a Selective Androgen Receptor Modulator, for the Prevention and Treatment of Muscle Wasting in Cancer Patients (POWER Trials)

(2016) Jeffrey Crawford et al.   Current Oncology Reports

Metabolite profiling of Dioscorea (yam) species reveals underutilised biodiversity and renewable sources for high-value compounds

(2016) Elliott J. Price et al.   Scientific Reports

The efficacy, bioavailability and safety of a novel hydroalcoholic testosterone gel 2% in hypogonadal men: results from phase II open-label studies

(2015) M. Efros et al.   ANDROLOGIA

Synthetic Androgens as Designer Supplements

(2015) Jan Joseph et al.   Current Neuropharmacology

Enobosarm (GTx-024, S-22): a potential treatment for cachexia

(2014) Reshmi Srinath et al.   Future Oncology

Ethnobotany, phytochemistry, and bioactivity of the genus Turnera (Passifloraceae) with a focus on damiana—Turnera diffusa

(2014) Katarzyna Szewczyk et al.   JOURNAL OF ETHNOPHARMACOLOGY

Transdermal testosterone replacement therapy in men

(2014) Christian Koch et al.   Drug Design Development and Therapy

Anabolic—Androgenic Steroids

(2013) Donald G. Barceloux et al.   DM DISEASE-A-MONTH

Effects of enobosarm on muscle wasting and physical function in patients with cancer: a double-blind, randomised controlled phase 2 trial

(2013) Adrian S Dobs et al.   LANCET ONCOLOGY

The long-term efficacy and safety of a testosterone mucoadhesive buccal tablet in testosterone-deficient men

(2012) Wallace W. Dinsmore et al.   BJU INTERNATIONAL

7α-Methyl-19-nortestosterone (MENTR): the Population Council's contribution to research on male contraception and treatment of hypogonadism

(2012) Eberhard Nieschlag et al.   CONTRACEPTION

Current Management Options for Hereditary Angioedema

(2012) Konrad Bork   CURRENT ALLERGY AND ASTHMA REPORTS

Emerging medication for the treatment of male hypogonadism

(2012) Giovanni Corona et al.   EXPERT OPINION ON EMERGING DRUGS

The Safety, Pharmacokinetics, and Effects of LGD-4033, a Novel Nonsteroidal Oral, Selective Androgen Receptor Modulator, in Healthy Young Men

(2012) Shehzad Basaria et al.   JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES

The Anabolic Androgenic Steroid Fluoxymesterone Inhibits 11 -Hydroxysteroid Dehydrogenase 2-Dependent Glucocorticoid Inactivation

(2012) C. Furstenberger et al.   TOXICOLOGICAL SCIENCES

Development of Dimethandrolone 17 -Undecanoate (DMAU) as an Oral Male Hormonal Contraceptive: Induction of Infertility and Recovery of Fertility in Adult Male Rabbits

(2011) B. J. Attardi et al.   JOURNAL OF ANDROLOGY

Abiraterone and Increased Survival in Metastatic Prostate Cancer

(2011) Johann S. de Bono et al.   NEW ENGLAND JOURNAL OF MEDICINE

The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double-blind, placebo-controlled phase II trial

(2011) James T. Dalton et al.   Journal of Cachexia Sarcopenia and Muscle

Δ4-Ethylestrenol in Recurrent Deep Venous Thrombosis

(2010) Bengt Nilsson et al.   ACTA MEDICA SCANDINAVICA

Discovery of the Selective Androgen Receptor Modulator MK-0773 Using a Rational Development Strategy Based on Differential Transcriptional Requirements for Androgenic AnabolismVersusReproductive Physiology

(2010) Azriel Schmidt et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Notch-1 Inhibition by Withaferin-A: A Therapeutic Target against Colon Carcinogenesis

(2010) S. Koduru et al.   MOLECULAR CANCER THERAPEUTICS

Tissue selectivity and potential clinical applications of trenbolone (17β-hydroxyestra-4,9,11-trien-3-one): A potent anabolic steroid with reduced androgenic and estrogenic activity

(2010) Joshua F. Yarrow et al.   STEROIDS

Design, Synthesis, and Preclinical Characterization of the Selective Androgen Receptor Modulator (SARM) RAD140

(2010) Chris P. Miller et al.   ACS Medicinal Chemistry Letters

Detection of the arylpropionamide-derived selective androgen receptor modulator (SARM) S-4 (Andarine) in a black-market product

(2009) Mario Thevis et al.   Drug Testing and Analysis

The antiandrogen cyproterone acetate: discovery, chemistry, basic pharmacology, clinical use and tool in basic research*

(2009) F. Neumann   EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES

Identification of Anabolic Selective Androgen Receptor Modulators with Reduced Activities in Reproductive Tissues and Sebaceous Glands

(2009) Azriel Schmidt et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Nonsteroidal Selective Androgen Receptor Modulators (SARMs): Dissociating the Anabolic and Androgenic Activities of the Androgen Receptor for Therapeutic Benefit

(2009) Michael L. Mohler et al.   JOURNAL OF MEDICINAL CHEMISTRY

Quassinoids fromEurycoma longifolia

(2009) Katsunori Miyake et al.   JOURNAL OF NATURAL PRODUCTS

Pharmacology of anabolic steroids

(2008) A T Kicman   BRITISH JOURNAL OF PHARMACOLOGY

Preclinical Characterization of a (S)-N-(4-Cyano-3-Trifluoromethyl-Phenyl)-3-(3-Fluoro, 4-Chlorophenoxy)-2-Hydroxy-2-Methyl-Propanamide: A Selective Androgen Receptor Modulator for Hormonal Male Contraception

(2008) Amanda Jones et al.   ENDOCRINOLOGY

Delivery of testosterone to the brain by intranasal administration: Comparison to intravenous testosterone

(2008) William A. Banks et al.   JOURNAL OF DRUG TARGETING

Pharmacokinetics and Pharmacodynamics of LGD-3303 [9-Chloro-2-ethyl-1-methyl-3-(2,2,2-trifluoroethyl)-3H-pyrrolo-[3,2-f]quinolin-7(6H)-one], an Orally Available Nonsteroidal-Selective Androgen Receptor Modulator

(2008) E. G. Vajda et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Pharmacological characterization of AC-262536, a novel selective androgen receptor modulator

(2007) Fabrice Piu et al.   JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY